Kc Chohan’s Post

View profile for Kc Chohan, graphic

Saving you 30-60% per year on taxes by using structures not loopholes.

📊 **Eli Lilly Increases Revenue Guidance Amid Strong Q2 2024 Results** Eli Lilly & Co. has once again showcased its robust market stance and operational prowess with stellar Q2 2024 financial results. The pharmaceutical giant reported a 9% year-over-year revenue increase, reaching $7.5 billion. Adjusted Earnings Per Share (EPS) also rose by 12%, reflecting strong investor confidence. New product launches significantly contributed to this growth, bolstered by a 15% rise in R&D investment. Additionally, Eli Lilly revised its full-year revenue guidance upward, now projecting a 10% to 12% growth, up from 8% to 10%. Key drivers behind these impressive results include successful new product launches, stringent cost management, a strong R&D pipeline with high-potential drugs, and geographic expansion into emerging markets. For investors, this means stronger financial health, promising growth potential, consistent dividend payouts, and potential stock price appreciation. Eli Lilly's raised revenue guidance attests to its effective strategic planning, solidifying its future growth prospects. 🔍 Discover how you can maximize tax savings during these prosperous times. Take the next step by reaching out to **Together CFO** or setting up a call using the link below. 👉 **_https://lnkd.in/gNmSEaig

To view or add a comment, sign in

Explore topics